Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects...

gan Pearlman David S, Miller S David, LaForce Craig, Oh Chad K, Parker Joseph M, Le Chenxiong, Robbie Gabriel J, White Wendy I, White Barbara, Molfino Nestor A
Cyhoeddwyd 2011-02-01

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects...

gan Parker, Joseph M, Oh, Chad K, LaForce, Craig, Miller, S David, Pearlman, David S, Le, Chenxiong, Robbie, Gabriel J, White, Wendy I, White, Barbara, Molfino, Nestor A
Cyhoeddwyd 2011

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

gan Schmidt, Sigrun Alba Johannesdottir, Johansen, Martin Berg, Olsen, Morten, Xu, Xiao, Parker, Joseph M, Molfino, Nestor A, Lash, Timothy L, Sørensen, Henrik Toft, Christiansen, Christian Fynbo
Cyhoeddwyd yn BMJ Open (2014)

Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency

gan Shapiro, Amy D., Nakar, Charles, Parker, Joseph M., Albert, Gary R., Moran, John E., Thibaudeau, Karen, Thukral, Neelam, Hardesty, Brandon M., Laurin, Pierre, Sandset, Per Morten
Cyhoeddwyd yn Blood (2018)

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis

gan Khalil, Nasreen, Manganas, Helene, Ryerson, Christopher J., Shapera, Shane, Cantin, Andre M., Hernandez, Paul, Turcotte, Eric E., Parker, Joseph M., Moran, John E., Albert, Gary R., Sawtell, Renata, Hagerimana, Aline, Laurin, Pierre, Gagnon, Lyne, Cesari, Frank, Kolb, Martin
Cyhoeddwyd yn Eur Respir J (2019)